Mutations can interfere with posttranscriptional expression of the HLA-A and -B genes. B-lymphoblastoid cells that contain one copy of the major histocompatibility complex (MHC) were subjected to mutagenesis and immunoselection for MHC antigen-loss mutants. Some mutations partially reduced surface expression of HLA-A and eliminated HLA-B expression concurrently, although the HLA-A and -B genes were present and transcribed. Antigen expression was fully restored in hybrids of these mutants with other Blymphoblastoid cells. Therefore, normal cell surface expression of the HLA-A and -B antigens on B lymphoblasts requires (1) execution of at least one trans-active step in the production of the antigens after transcription of the HLA-A and -B genes or (it) association ofthe class I antigens with other molecules. DNA analysis of one mutant suggests the possibility that a locus required for the normal expression of the HLA-A and -B antigens is located between the MHC complement genes and the HLA-DP all locus.
associate with the cell membrane in mouse (e.g., ref. 15 ) and human (e.g., refs. 16 and 17) cells. Expression of class I antigens on lymphocytes is also deficient in humans who are homozygous for recessive mutations that cause the "bare lymphocyte syndrome," although the genes and potential for their expression are present. The consequence in some cases is defective B-cell maturation, combined immunodeficiency disease, and early death (18) (19) (20) (21) (22) , whereas pathological manifestations are less severe in other cases (23) .
This paper describes a unique kind of derangement in class I antigen expression. Mutagenic treatment of human Blymphoblastoid cell lines (B-LCLs) resulted in isolation of mutants that had simultaneously reduced expressions of the A and B antigens even though the HLA-A and -B and the 32m genes were present and transcribed. We believe these class I-deficiency mutations are different from those that cause P2m deficiency and the bare lymphocyte syndrome (see Discussion) . Much information about the genetics, structure, and function of the human class I histocompatibility antigens exists (reviewed in refs. 1 and 2) but relatively little is known about how their expression is genetically regulated. We recently described mutations that concurrently perturb cell surface expression of the class I antigens HLA-A and -B on human B-lymphoblastoid cells (3) . This paper describes analysis of the mutants.
Class I antigens are found on the surfaces of nucleated somatic cells. These antigens are recognized on allogeneic cells by cytolytic T lymphocytes (CTL) and also function in recognition by CTL of autologous cells that are infected with viruses or that are otherwise antigenically altered (4)-e.g., as in malignant cells. Hereditary predisposition to diverse diseases is associated with the presence of specific class I alleles in humans (e.g., refs. 5 and 6).
Each class I antigen consists of a 44,000-dalton a chain and a 12,000-dalton ( chain, P2-microglobulin (32m). In humans three highly polymorphic genes encode the a chains of the familiar class I antigens: HLA-A, -B, -C. These genes and antigens will be referred to as A, B, and C below. The locus encoding (32m is on human chromosome (Chr) 15 (7) , whereas the A, B, and C genes are located in the major histocompatibility complex (MHC) on the Chr 6 short arm (8) . Recombinant DNA probes and HLA deletion mutants have been used to identify additional class I DNA near the A locus (9) (10) (11) . Phenotypic expressions of these genes have not been defined, although some of them are probably homologous to the murine antigen-encoding TL and Qa genes (12) (13) (14) .
EXPERIMENTAL PROCEDURES Cells, Media, and Mutagenesis. Mutants ( Fig. 1) were derived from B-LCL 721 (24) and are identified by decimal numbers-e.g., . 45 . The origins and some properties of mutants .45, .61, .127, .134, .144, .174, and .180 have been described (3, 9, (24) (25) (26) (27) . Mutants .184 and SPOT are described below. Cells were grown in GIBCO RPMI 1640 medium (85 vol) with heat-inactivated fetal bovine serum (15 vol) (RPMI/fetal calf serum). Procedures for propagating the cells, for y-ray mutagenesis, and for isolating antigen-loss mutants are published (24, 25 (Pi/NaCl) (28) . Rapidly growing cells (5 x 106 of each type) were mixed and washed once with 10 ml of Pi/NaCl, and the supernatant fluid was discarded. The 50% PEG (0.5 ml) at 370C was added dropwise to the cell pellet, which was partly dissociated by stirring. After 2-3 min, 9 ml of medium was added, initially dropwise, during a 2-to 3-min interval. The cells were dispersed, pelleted, and resuspended in RPMI/ fetal calf serum. Aliquots (1.0 ml) were distributed into 24-well plates (Nunc). After 24 hr, wells were supplemented to contain hybrid-selection medium, which was renewed at 1-week intervals. Independent hybrids were isolated from separate wells.
Glyoxylase I Characterizations. Glyoxylase I characterizations were performed as described (24 (10) . Probing for the HLA-A and -B loci was performed with locus-specific probes pHLA-2a.1 (A locus) and pHLA-1.1 (B locus) (32 10 1.l; 650C for 5 min. After electrophoresis, RNA was transferred (4 hr) onto nitrocellulose by using a vacuum grid and the filter was baked for 2 hr at 80'C in a vacuum oven. Prehybridization was according to ref. 35 by using 50% formamide, 0.75 M sodium chloride/75 mM sodium citrate, 50 mM sodium phosphate, 1% glycine, 5x concentrated Denhardt's solution (0.02% polyvinylpyrrolidone/0.02% Ficoll/0.2% bovine serum albumin), and 500 ug of salmon sperm DNA per ml at 420C for 12-15 hr. Hybridization was as described (32) . Blots were washed with 15 mM sodium chloride/1.5 mM sodium citrate at 650C for 1 hr and exposed to Kodak XAR-5 film. (36) , or A2 (9, 25) had permitted isolation ofmutants from which an entire MHC haplotype was deleted. The haplotype remaining in such mutants could then be mutagenized to produce homozygous mutants that had null expression of MHC loci (e.g., refs. 3, 9, 10, 25). Mutants .61 and .134 originated in this way in different experiments. Mutant .45 (total of 1.6 x 107 cells), from which one haplotype had been deleted, was irradiated (300 rads) and, after 5 days, 1.1 x 105 surviving clone-forming cells were exposed to complement and anti-A2 mAb BB7.2. Mutants .61 and .134 were among nine A2-loss mutants that were isolated in the two experiments.
Mutants .174 and .180 were isolated in one experiment after -irradiation (300 rads) of mutant .45 followed by selection with complement and mAbs CC6. 4 and .174 are phenotypically B-null-i.e., binding of mAb 4D12 to these mutants was not significantly greater than that to the negative controls. This confirms our previous conclusion based on inability of B5-specific alloantisera to lyse the mutants and on reduced mAb binding determined by ELISA (3 (Fig. 1) , a HPRT-, ouar derivative of .127, from which the A2 and B5 genes had been deleted (9, 25) . Five hybrids from each cross were analyzed. Since the parental cells have different glyoxylase I allotypes, hybrids that contained a Chr 6 from both parents expressed a glyoxylase I 1-2 heterodimer (Fig. 5) . Binding of mAbs BB7.2 and 4D12 assayed with a FACS (Table 1) and ELISA (not shown) showed that cell surface expressions of the A2 and B5 antigens were fully restored in the hybrids. The results were most striking for B5, the expression of which was increased 29-to 114-fold. The relative increase in A2 expression was less marked but was significant because it was observed in 15/15 independent hybrids. The important point is that cell fusion restored the expressions ofboth the A2 and B5 antigens to those observed in the A2', B5+ control . 45 (41) , is absent (unpublished).
MHC locations of the class I-deficiency mutant loci in .61, .134, and .174 would mean they are distinct from the f2m locus on Chr 15 and from the bare lymphocyte syndrome mutant loci, which are inherited as if unlinked to the MHC (18, 22, 42) . This interpretation is supported by results of others. Howell et al. (43) showed that expression of class I antigens is greater on human B-LCLs than T-lymphoblastoid cell lines (T-LCLs) and that expression of the T-cell-encoded antigens was enhanced in B-LCL-T-LCL hybrids. Later, expression of the T-cell-encoded antigens was enhanced in a hybrid produced by fusing a T-LCL with B-cell mutant .174 (38) . Therefore, the B-cellderived factor that enhanced T-cell-encoded class I expressions cannot be located in the region of homozygous deletion in mutant .174. The A2 and BS antigens encoded by .174 were strongly displayed on the hybrid cells, in agreement with the cell hybridization experiments described herein. Furthermore, when the hybrid lost both T-cell-derived Chr 
